Abstract
Preparing for a clinical study on implant-enhance stroke rehabilitation Martin Schuettler, Chief Technology Officer at CorTec GmbH, addresses key questions around the development of the company’s innovative Brain Interchange System to support stroke rehabilitation therapy. CorTec has developed the Brain Interchange (BIC) implant system to improve stroke rehabilitation outcomes by enhancing the effect of conventional physio and/or occupational therapy. (1, 2) The effectiveness of the new implant-supported therapy will be investigated in an early feasibility study planned for 2024 to be carried out in Washington, US. While working on the approval of the feasibility study, uncertainties and unknowns of the study are investigated. These involve questions around usability and technical performance.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
